Food & beverages

WP 29 releases an extensive opinion on data processing at work

Inge Vanderreken

The EU’s “Article 29 Working Party” (WP29) has adopted new guidance on the processing of personal data in the employment context (the New Opinion). This New Opinion complements their 2001 opinion and 2002 working document. WP29 is the Data Protection Working Party established by Article 29 of Directive 95/46/EC. It is an independent European advisory Read More

CJEU to rule on milestone in European GMO legislation: the legal classification of mutagenesis in plant breeding

Geert Glas

With the development of new plant breeding techniques, the European plant breeding sector is tackling the world’s crucial challenge of feeding the 21st-century world. New plant breeding techniques allow for much faster and more precise results than traditional plant breeding techniques, and allow for more food to be produced with fewer inputs.  However, the novel Read More

CJEU confirms that generally accepted nutrition and health principles are a legitimate factor for the evaluation of health claims made on food

Patricia Carmona Botana

On 8 June 2017, the Court of Justice of the European Union (CJEU) issued a judgment in case Dextro Energy GmbH & Co. KG (Dextro) vs European Commission (Commission) (case C-296/16 P). The judgment confirms a March 2016 ruling of the General Court (GC), which found that the Commission was right in rejecting certain health Read More

Food Supplements: CJEU sets boundaries to national legislation imposing maximum amounts on nutrients

Patricia Carmona Botana

On 27 April 2017, the Court of Justice of the European Union (CJEU) issued a judgment on the interpretation of Directive 2002/46/EC on food supplements (Directive) (case C-672/15). The CJEU ruled that the Directive and the provisions on the free movement of goods in the Treaty on the Functioning of the European Union (TFEU) preclude Read More

The A&O CRISPR microsite: Everything you need to know about CRISPR in the one place

Marc Döring

The characterisation and optimisation of the CRISPR (also known as CRISPR/Cas) system for gene editing and other applications is undoubtedly one of the most powerful and ground breaking advances in the history of biotechnology. CRISPR technology holds the potential to revolutionise the treatment of disease by enabling DNA to be cut at precise locations, allowing Read More